Tibet AIM Pharm. Inc. (002826.SZ) SHZ
16.68
-0.17(-1.01%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
16.68
-0.17(-1.01%)
Currency In CNY
| Market Cap | 3.4B |
| Enterprise Value | 2.88B |
| P/E Ratio | 31.89 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 4.66 |
| Price/Book Ratio | 3.56 |
| Enterprise/Revenue | 4.01 |
| Enterprise/EBITDA | 20.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.14 |
| Operating Margin | 0.15 |
| Return On Assets | 0.08 |
| Return On Equity | 0.12 |
| Revenue | 636.27M |
| Revenue/Share | 3.75 |
| Gross Profit | 522.46M |
| EBITDA | 133.81M |
| Net Income | 92.58M |
| Diluted EPS | 0.5 |
| Total Cash | 633.56M |
| Total Cash/Share | 3.55 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.78 |
| Book Value Per Share | 4.69 |
| 52-Week Change | 36.95 |
| 52-Week High | 26.83 |
| 52-Week Low | 13.4 |
| Moving Average 50 Days | 19.56 |
| Moving Average 200 Days | 19.52 |
| Average Volume | 6.13M |
| Shares Outstanding | 187.27M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 0.6 |
| Payout Ratio | 0.21 |
| Last Split Factor | N/A |
| Last Split Date | N/A |